Polish public radio frames Ozempic and similar drugs as driving a health crisis. Only the headline is available, so tap through for its argument.
Recap by typeshit. Full story at www.polskieradio.pl.
The Sunrise health expert says unregulated peptide use can put people in hospital, and in the worst cases leave them needing a new liver.
Some people on weight loss drugs are testing lower doses, hoping for fewer side effects. ThePrint reports on the trend, which these users describe themselves.
Bell raises the question of muscle loss for people losing weight on a GLP-1 and notes it isn't medical advice, pointing viewers to their doctor.
Dr. Woo points to the official position of the AAO and NANOS on whether routine eye exams just to check for NAION are needed.
UC Berkeley researchers started mice on the drug at 20 months and report they also kept strength and memory. Published in Nature.
Lilly is widening its legal push against the black market for its experimental obesity shot, which still has no approval.
Loading…